✦ LIBER ✦

Human papillomavirus vaccines: a complex decision focused on cancer prevention and cost-effectiveness

✍ Scribed by David Jenkins

Book ID: 117791044
Publisher: The Lancet
Year: 2008
Tongue: English
Weight: 41 KB
Volume: 8
Category: Article
ISSN: 1473-3099
DOI: 10.1016/s1473-3099(08)70211-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of human pap

Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria

✍ Ingrid Zechmeister; Birgitte Freiesleben de Blasio; Geoff Garnett; Aileen Rae Ne 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 619 KB

PCN53 COST-EFFECTIVENESS OF HUMAN PAPILL

PCN53 COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINE FOR PREVENTION OF CERVICAL CANCER IN TAIWAN

✍ PH Liu; JD Wang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Cost-effectiveness of human papillomavir

Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand

✍ M Sharma; J Ortendahl; E van der Ham; S Sy; JJ Kim 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Human papillomavirus testing with Pap tr

Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis

✍ Shalini L Kulasingam; Raghu Rajan; Yvan St Pierre; C Victoria Atwood; Evan R Mye 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 285 KB

Recombinant vaccines for the prevention

Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer

✍ Kenneth E. Palmer; A. Bennett Jenson; J. Calvin Kouokam; Amanda B. Lasnik; Shin- 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 565 KB

Cost-effectiveness analysis of cervical

Cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of China

✍ Carol E. Levin; John Sellors; Ju-Fang Shi; Li Ma; You-lin Qiao; Jesse Ortendahl; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 250 KB 👁 2 views

## Abstract This study assessed the cost‐effectiveness of a new, rapid human papillomavirus (HPV)‐DNA screening test for cervical cancer prevention in the high‐risk region of Shanxi, China. Using micro‐costing methods, we estimated the resources needed to implement preventive strategies using cervi